INS and diabetes mellitus: While the direct evidence regarding β-cell protection is limited, p-coumaric acid (100 mg/kg body weight) administration has been demonstrated by animal studies to lower blood glucose levels, increase circulating insulin levels, and restore the level of glutathione, a key non-enzymatic antioxidant, in rats with STZ-induced diabetes [134].